Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.

Nirvanappa, Anilkumar C; Mohan, Chakrabhavi Dhananjaya; Rangappa, Shobith; Ananda, Hanumappa; Sukhorukov, Alexey Yu; Shanmugam, Muthu K; Sundaram, Mahalingam S; Nayaka, Siddaiah Chandra et al. · PLoS One · 2017

Where this comes from

Record sourced from PubMed, PMID 28384360.
Also identified by DOI 10.1371/journal.pone.0175659 and PMC identifier 5383341.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0163209.].

Read the full text

View on PubMed · Publisher (DOI)